Eterna Therapeutics Inc (NAS:ERNA)
$ 2.06 0.07 (3.52%) Market Cap: 11.14 Mil Enterprise Value: 53.48 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 31/100

Brooklyn Immunotherapeutics Inc at Benzinga Global Small Cap Investor Conference (Virtual) Transcript

Dec 08, 2021 / 09:40PM GMT
Release Date Price: $118.8 (+1.19%)
Spencer Israel
Benzinga - Managing Editor

Let's keep the show moving here. We got a couple presentations left. There is our next speaker; he's already here. Dr. Howard Federoff, he is the CEO of ImmunoTherapeutics. How are we doing today, sir?

Howard Federoff
Brooklyn ImmunoTherapeutics, Inc. - CEO

Great. How are you, Spencer?

Spencer Israel
Benzinga - Managing Editor

I'm doing well. It's Wednesday, which means we're over the hump coming down to the back half of the week. Take us home, Howard.

Howard Federoff
Brooklyn ImmunoTherapeutics, Inc. - CEO

All right. It's my pleasure. It's great to be with you.

Spencer Israel
Benzinga - Managing Editor

All right.

Howard Federoff
Brooklyn ImmunoTherapeutics, Inc. - CEO

So today, I'm going to be talking about an approach that probably is familiar, but let me start by recognizing our exceptional management team, many of whom have

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot